Cargando…
The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice
Both TDP-43 pathology and failure of RNA editing of AMPA receptor subunit GluA2, are etiology-linked molecular abnormalities that concomitantly occur in the motor neurons of the majority of patients with amyotrophic lateral sclerosis (ALS). AR2 mice, in which an RNA editing enzyme adenosine deaminas...
Autores principales: | Akamatsu, Megumi, Yamashita, Takenari, Hirose, Naoki, Teramoto, Sayaka, Kwak, Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923865/ https://www.ncbi.nlm.nih.gov/pubmed/27350567 http://dx.doi.org/10.1038/srep28649 |
Ejemplares similares
-
Testing of the therapeutic efficacy and safety of AMPA receptor RNA aptamers in an ALS mouse model
por: Akamatsu, Megumi, et al.
Publicado: (2022) -
Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons
por: Yamashita, Takenari, et al.
Publicado: (2017) -
Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis
por: Yamashita, Takenari, et al.
Publicado: (2017) -
Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons
por: Yamashita, Takenari, et al.
Publicado: (2013) -
Extracellular RNAs as Biomarkers of Sporadic Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases
por: Hosaka, Takashi, et al.
Publicado: (2019)